WO2003068943A3 - Secreted proteins - Google Patents
Secreted proteins Download PDFInfo
- Publication number
- WO2003068943A3 WO2003068943A3 PCT/US2003/004712 US0304712W WO03068943A3 WO 2003068943 A3 WO2003068943 A3 WO 2003068943A3 US 0304712 W US0304712 W US 0304712W WO 03068943 A3 WO03068943 A3 WO 03068943A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- secp
- secreted proteins
- polynucleotides
- agonists
- diagnosing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003211112A AU2003211112A1 (en) | 2002-02-13 | 2003-02-13 | Secreted proteins |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35700202P | 2002-02-13 | 2002-02-13 | |
US60/357,002 | 2002-02-13 | ||
US36243902P | 2002-03-06 | 2002-03-06 | |
US60/362,439 | 2002-03-06 | ||
US36604102P | 2002-03-19 | 2002-03-19 | |
US60/366,041 | 2002-03-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003068943A2 WO2003068943A2 (en) | 2003-08-21 |
WO2003068943A3 true WO2003068943A3 (en) | 2005-02-10 |
Family
ID=27739172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/004712 WO2003068943A2 (en) | 2002-02-13 | 2003-02-13 | Secreted proteins |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003211112A1 (en) |
WO (1) | WO2003068943A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003270439B2 (en) * | 2002-09-11 | 2009-09-24 | Genentech, Inc. | Novel composition and methods for the treatment of immune related diseases |
ES2772674T3 (en) * | 2005-05-12 | 2020-07-08 | Zymogenetics Inc | Compositions and methods for modulating immune responses |
CA2719189C (en) | 2008-04-09 | 2020-08-04 | Genentech, Inc. | Novel compositions and methods for the treatment of immune related diseases |
WO2014059028A1 (en) | 2012-10-09 | 2014-04-17 | Igenica, Inc. | Anti-c16orf54 antibodies and methods of use thereof |
EP3789036A1 (en) | 2013-07-16 | 2021-03-10 | F. Hoffmann-La Roche AG | Methods of treating cancer using pd-1 axis binding antagonists and tigit inhibitors |
WO2015161247A1 (en) * | 2014-04-17 | 2015-10-22 | Igenica Biotherapeutics, Inc. | Humanized anti-c16orf54 antibodies and methods of use thereof |
AU2016325610B2 (en) | 2015-09-25 | 2019-10-10 | Genentech, Inc. | Anti-TIGIT antibodies and methods of use |
CN110662552A (en) | 2016-11-30 | 2020-01-07 | 昂科梅德制药有限公司 | Methods of cancer treatment comprising TIGIT binding agents |
AU2019324170A1 (en) | 2018-08-23 | 2021-02-18 | Seagen, Inc. | Anti-TIGIT antibodies |
-
2003
- 2003-02-13 WO PCT/US2003/004712 patent/WO2003068943A2/en not_active Application Discontinuation
- 2003-02-13 AU AU2003211112A patent/AU2003211112A1/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
DATABASE GENBANK [online] 8 September 2000 (2000-09-08), TANG ET AL.: "CDNA encoding a human secretory protein", XP002983112, accession no. EMBL Database accession no. (AAA75121) * |
Also Published As
Publication number | Publication date |
---|---|
AU2003211112A8 (en) | 2003-09-04 |
WO2003068943A2 (en) | 2003-08-21 |
AU2003211112A1 (en) | 2003-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003027228A3 (en) | Receptors and membrane-associated proteins | |
WO2002038602A3 (en) | Secreted proteins | |
WO2003048305A3 (en) | Receptors and membrane-associated proteins | |
WO2002048337A3 (en) | Secreted human proteins | |
WO2001098353A3 (en) | Secreted proteins | |
WO2003029437A3 (en) | Secreted proteins | |
WO2002072794A3 (en) | Immunoglobulin superfamily proteins | |
WO2001079291A3 (en) | Secreted proteins | |
WO2003004615A3 (en) | Secreted proteins | |
WO2003070902A3 (en) | Receptors and membrane-associated proteins | |
WO2003068943A3 (en) | Secreted proteins | |
WO2002086069A3 (en) | Secreted proteins | |
WO2002070669A3 (en) | Secreted proteins | |
WO2002097060A3 (en) | Carbohydrate-associated proteins | |
WO2004044165A3 (en) | Lipid-associated proteins | |
WO2004048550A3 (en) | Immune response associated proteins | |
WO2003062391A3 (en) | Structural and cytoskeleton-associated proteins | |
WO2002026982A3 (en) | Secreted human proteins | |
WO2003087300A3 (en) | Secreted proteins | |
WO2003025130A3 (en) | Receptors and membrane-associated proteins | |
WO2002066646A3 (en) | Neurotransmission-associated proteins | |
WO2003016506A3 (en) | Secreted proteins | |
WO2002079441A3 (en) | Secreted proteins | |
WO2003063769A3 (en) | Vesicle-associated proteins | |
WO2001051636A3 (en) | Secreted proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003739830 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2003739830 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |